These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

415 related items for PubMed ID: 25701034

  • 21. Cell-penetrating peptide-siRNA conjugate loaded YSA-modified nanobubbles for ultrasound triggered siRNA delivery.
    Xie X, Yang Y, Lin W, Liu H, Liu H, Yang Y, Chen Y, Fu X, Deng J.
    Colloids Surf B Biointerfaces; 2015 Dec 01; 136():641-50. PubMed ID: 26492155
    [Abstract] [Full Text] [Related]

  • 22. Enhancing siRNA-based cancer therapy using a new pH-responsive activatable cell-penetrating peptide-modified liposomal system.
    Xiang B, Jia XL, Qi JL, Yang LP, Sun WH, Yan X, Yang SK, Cao DY, Du Q, Qi XR.
    Int J Nanomedicine; 2017 Dec 01; 12():2385-2405. PubMed ID: 28405163
    [Abstract] [Full Text] [Related]

  • 23. Synergistic targeted delivery of payload into tumor cells by dual-ligand liposomes co-modified with cholesterol anchored transferrin and TAT.
    Tang J, Zhang L, Liu Y, Zhang Q, Qin Y, Yin Y, Yuan W, Yang Y, Xie Y, Zhang Z, He Q.
    Int J Pharm; 2013 Sep 15; 454(1):31-40. PubMed ID: 23850793
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Cytoplasm-responsive nanocarriers conjugated with a functional cell-penetrating peptide for systemic siRNA delivery.
    Tanaka K, Kanazawa T, Horiuchi S, Ando T, Sugawara K, Takashima Y, Seta Y, Okada H.
    Int J Pharm; 2013 Oct 15; 455(1-2):40-7. PubMed ID: 23911914
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Novel cell penetrating peptides with multiple motifs composed of RGD and its analogs.
    Mokhtarieh AA, Kim S, Lee Y, Chung BH, Lee MK.
    Biochem Biophys Res Commun; 2013 Mar 08; 432(2):359-64. PubMed ID: 23384441
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Delivery of siRNA Using Cationic Liposomes Incorporating Stearic Acid-modified Octa-Arginine.
    Yang D, Li Y, Qi Y, Chen Y, Yang X, Li Y, Liu S, Lee RJ.
    Anticancer Res; 2016 Jul 08; 36(7):3271-6. PubMed ID: 27354583
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. APN/CD13-targeting as a strategy to alter the tumor accumulation of liposomes.
    Dunne M, Zheng J, Rosenblat J, Jaffray DA, Allen C.
    J Control Release; 2011 Sep 25; 154(3):298-305. PubMed ID: 21640146
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.